Hemant Bhutani

Statistics

Publications

Citations

492

H-Index

Active since

2002

Affiliations

National Institute of Pharmaceutical Education and Research(Current)

Bristol-Myers Squibb (India)

Syngene International (India)

Biocon (India)

Panacea Biotec (India)

Hemant Bhutani is an author at National Institute of Pharmaceutical Education and Research specializing in pharmacy, pharmaceutical analysis, and pharmacology.

ORCID

Publications per year

2002–2021

Publications

LC and LC-MS study of stress decomposition behaviour of isoniazid and establishment of validated stability-indicating assay method

Hemant Bhutani, Saranjit Singh, Sanjay Vir et al. · Journal of Pharmaceutical and Biomedical Analysis · 2006 · 113 citations

Pharmacy, Biochemistry, Pharmaceutical Analysis +14

Mechanistic explanation to the catalysis by pyrazinamide and ethambutol of reaction between rifampicin and isoniazid in anti-TB FDCs

Hemant Bhutani, Saranjit Singh, K.C. Jindal et al. · Journal of Pharmaceutical and Biomedical Analysis · 2005 · 60 citations

Pharmacy, Chemistry, Pharmacology +9

ICH guidance in practice: Validated stability-indicating HPLC method for simultaneous determination of ampicillin and cloxacillin in combination drug products

Vijay Kumar, Hemant Bhutani, Saranjit Singh · Journal of Pharmaceutical and Biomedical Analysis · 2006 · 49 citations

Pharmacy, Pharmaceutical Analysis, Pharmaceutics +6

The physical and chemical stability of anti-tuberculosis fixed-dose combination products under accelerated climatic conditions.

Hemant Bhutani, T. Thanga Mariappan, Sarman Singh · PubMed · 2004 · 44 citations

Pharmacy, Pharmaceutical Analysis, Pharmacology +17

Drug-Drug Interaction Studies on First-Line Anti-tuberculosis Drugs

Hemant Bhutani, Saranjit Singh, K.C. Jindal · Pharmaceutical Development and Technology · 2005 · 35 citations

Pharmacy, Pharmaceutical Analysis, Pharmacology +15

1–5 of 15